With commercial stage products and a promising pipeline, we are Servier Group, a unique global organization headquartered in France. Operating in more than 150 countries and governed by a non-profit foundation, we have multiple medicines approved in oncology, cardiology, and other therapeutic areas. Servier’s 2030 Ambition aims to establish the Group as a recognized, innovative, and patient-centered leader in Oncology, Neurology, and Cardiometabolism & Venous Diseases (CMVD). Over half of our research and development efforts are focused on targeted therapies to address unmet patient needs. Within Servier Industry, the Manufacturing Science and Analytical Technology (MSAT) organization plays a key role in driving technical excellence, industrial transformation, and lifecycle management — enabling manufacturing robustness, quality, and compliance across all product modalities and technologies. Reporting to the Head of Oral Solids Drug Product - MSAT, this global role leads a team of subject matter experts (SMEs) responsible for supporting commercialization, manufacturing and lifecycle management of Oncology and Neurology related oral solid drug products across internal and external manufacturing sites. This role will collaborate with relevant Site MSAT teams and partner with CMC and Industry stakeholders to ensure consistent, robust, and compliant manufacturing process performance. This is a key global leadership position where the incumbent, in collaboration with MSAT Leadership Team, will contribute to shaping Servier’s Global MSAT function in alignment with corporate and Industry vision, driving innovation, continuous improvement, sustainability, and global collaboration for the Oncology and Neurology OSD product portfolio.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Education Level
Ph.D. or professional degree